Hur effektiva är orala preventivmedel innehållande drospirenon i kombination med etinylöstradiol vid behandling av premenstruella symtom?
Background: Premenstrual syndrome (PMS) are common in more than 75 % of all women with menstruation. The prevalence of moderate to severe PMS is 20-40 % and the prevalence of premenstrual dysphoric disorder (PMDD) is 3-8 %. PMS occur in the form of physical and psychological symptoms a few weeks bef...
Main Author: | |
---|---|
Format: | Others |
Language: | Swedish |
Published: |
Linnéuniversitetet, Institutionen för kemi och biomedicin (KOB)
2020
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-95322 |